BioVectra PEI Inc.

BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, with GMP outsourcing solutions for raw materials, intermediates, APIs & biologic drug substances. They are focused on contract manufacturing and product development of active pharmaceutical ingredients, pharmaceutical intermediates, and bioreagents. BIOVECTRA has expertise in microbial fermentation with a 64,000 L fermentation capacity. They offer services for small molecules, pDNA/mRNA manufacturing, HPAPIs and bioreagents. The company was acquired by Agilent Technologies in 2024. They also have a new mRNA vaccine manufacturing facility in P.E.I.